Dendritic cells and innate immunity in kidney transplantation

Kidney International

Volumn 87, Issue 4, 2015, Pages 712-718

  Zhuang, Quan ^a,b   Lakkis, Fadi G ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute rejection; Ischemia reperfusion; Lymphocytes

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL INTERACTION; CELL MIGRATION; COMPARATIVE EFFECTIVENESS; DANGER ASSOCIATED MOLECULAR PATTERN; DENDRITIC CELL; GRAFT RECIPIENT; HELPER CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; KIDNEY DONOR; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOLECULAR BIOLOGY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ALLOGRAFT; ANIMAL; GRAFT REJECTION; IMMUNOLOGY;

ALLOGRAFTS; ANIMALS; DENDRITIC CELLS; HOST VS GRAFT REACTION; HUMANS; IMMUNITY, INNATE; KIDNEY TRANSPLANTATION; MONOCYTES; T-LYMPHOCYTES;

EID: 84926516228     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.430     Document Type: Review

References (69)

1. USRDS. Atlas of ESRD. http://www.usrds.org/2013/view/Default.aspx 2013.
2. Lakkis FG, Lechler RI. Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med 2013; 3, pii: a014993. doi:10.1101/cshperspect.a014993.
3. Abbas AK, Janeway CA Jr. Immunology: improving on nature in the twenty-first century. Cell 2000; 100: 129-138.
4. Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989; 54 Pt 1: 1-13.
5. Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291-295.
6. Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev 2010; 234: 5-17.
7. Nelson PJ, Rees AJ, Griffin MD et al. The renal mononuclear phagocytic system. J Am Soc Nephrol 2012; 23: 194-203.
8. Morelli AE. Dendritic cells of myeloid lineage: the masterminds behind acute allograft rejection. Curr Opin Organ Transplant 2014; 19: 20-27.
9. Gould DS, Auchincloss H. Direct and indirect recognition: the role of MHC antigens in graft rejection. Immunol Today 1999; 20: 77-82.
10. Macedo C, Orkis EA, Popescu I et al. Contribution of näve and memory T-cell populations to the human alloimmune response. Am J Transplant 2009; 9: 2057-2066.
11. Suchin EJ, Langmuir PB, Palmer E et al. Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question. J Immunol 2001; 166: 973-981.
12. Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens: A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307-314.
13. Lafferty KJ, Bootes A, Dart G et al. Effect of organ culture on the survival of thyroid allografts in mice. Transplantation 1976; 22: 138-149.
14. Talmage DW, Dart G, Radovich J et al. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976; 191: 385.
15. Bowen KM, Andrus L, Lafferty KJ. Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes 1980; 29(Suppl 1): 98-104.
16. Batchelor JR, Welsh KI, Maynard A et al. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. I. Retransplantation of (AS X AUG)F1 kidneys into secondary AS recipients. J Exp Med 1979; 150: 455-464.
17. Welsh KI, Batchelor JR, Maynard A et al. Failure of long surviving, passively enhanced kidney allografts to provoke T-dependent alloimmunity. II. Retransplantation of (AS X AUG)F1 kidneys from AS primary recipients into (AS X WF)F1 secondary hosts. J Exp Med 1979; 150: 465-470.
18. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31-41.
19. Mandelbrot DA, Furukawa Y, McAdam AJ et al. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. J Immunol 1999; 163: 3753-3757.
20. Campos L, Naji A, Deli BC et al. Survival of MHC-deficient mouse heterotopic cardiac allografts. Transplantation 1995; 59: 187-191.
21. Mannon RB, Griffiths R, Ruiz P et al. Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection. Kidney Int 2002; 62: 290-300.
22. Grusby MJ, Auchincloss H Jr., Lee R et al. Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci USA 1993; 90: 3913-3917.
23. Garrod KR, Liu FC, Forrest LE et al. NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol 2010; 184: 2329-2336.
24. Garrod KR, Wei SH, Parker I et al. Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHCmismatched targets. Proc Natl Acad Sci USA 2007; 104: 12081-12086.
25. Herrera OB, Golshayan D, Tibbott R et al. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004; 173: 4828-4837.
26. Sivaganesh S, Harper SJ, Conlon TM et al. Copresentation of intact and processed MHC alloantigen by recipient dendritic cells enables delivery of linked help to alloreactive CD8 T cells by indirect-pathway CD4 T cells. J Immunol 2013; 190: 5829-5838.
27. Wakim LM, Bevan MJ. Cross-dressed dendritic cells drive memory CD8 T-cell activation after viral infection. Nature 2011; 471: 629-632.
28. Sallusto F, Lenig D, Fö rster R et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
29. Lakkis FG, Arakelov A, Konieczny BT et al. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nature Med 2000; 6: 686-688.
30. Chalasani G, Dai Z, Konieczny BT et al. Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc. Natl. Acad. Sci. USA 2002; 99: 6175-6180.
31. Obhrai JS, Oberbarnscheidt MH, Hand TW et al. Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol 2006; 176: 4051-4058.
32. Gelman AE, Li W, Richardson SB et al. Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs. J Immunol 2009; 182: 3969-3973.
33. Zhou P, Hwang KW, Palucki D et al. Secondary lymphoid organs are important but not absolutely required for allograft responses. Am J Transplant 2003; 3: 259-266.
34. Kant CD, Akiyama Y, Tanaka K et al. Primary vascularization of allografts governs their immunogenicity and susceptibility to tolerogenesis. J Immunol 2013; 191: 1948-1956.
35. Nasr IW, Reel M, Oberbarnscheidt MH et al. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant 2007; 7: 1071-1079.
36. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific, IFN-g-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J. Immunol 1999; 163: 2267-2275.
37. Heath WR, Carbone FR. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009; 10: 1237-1244.
38. Celli S, Albert ML, Bousso P. Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy. Nat Med 2011; 17: 744-749.
39. Walch JM, Zeng Q, Li Q et al. Cognate antigen directs CD8 T cell migration to vascularized transplants. J Clin Invest 2013; 123: 2663-2671.
40. Wakim LM, Waithman J, van Rooijen N et al. Dendritic cell-induced memory T cell activation in nonlymphoid tissues. Science 2008; 319: 198-202.
41. Larsen CP, Steinman RM, Witmer-Pack M et al. Migration and maturation of Langerhans cells in skin transplants and explants. J Exp Med 1990; 172: 1483-1493.
42. Oberbarnscheidt MH, Zeng Q, Li Q et al. Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 2014; 124: 3579-3589.
43. Oberbarnscheidt MH, Zecher D, Lakkis FG. The innate immune system in transplantation. Semin Immunol 2011; 23: 264-272.
44. Mori DN, Kreisel D, Fullerton JN et al. Inflammatory triggers of acute rejection of organ allografts. Immunol Rev 2014; 258: 132-144.
45. Hall BM, Dorsch S, Roser B. The cellular basis of allograft rejection in vivo. I. The cellular requirements for first-set rejection of heart grafts. J Exp Med 1978; 148: 878-889.
46. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-1151.
47. Zecher D, Li Q, Williams AL et al. Innate immunity alone is not sufficient for chronic rejection but predisposes healed allografts to T cell-mediated pathology. Transpl Immunol 2012; 26: 113-118.
48. Graham JA, Wilkinson RA, Hirohashi T et al. Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway. Am J Transplant 2009; 9: 2479-2484.
49. Kroemer A, Xiao X, Degauque N et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180: 7818-7826.
50. Kirk AD, Hale DA, Mannon RB et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003; 76: 120-129.
51. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991-1045.
52. Rao DA, Pober JS. Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 2008; 28: 229-248.
53. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008; 8: 279-289.
54. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
55. Sporri R, Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4 T cell populations lacking helper function. Nat Immunol 2005; 6: 163-170.
56. Tesar BM, Zhang J, Li Q et al. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a toll-like receptor signal adaptor protein. Am J Transplant 2004; 4: 1429-1439.
57. McKay D, Shigeoka A, Rubinstein M et al. Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 2006; 36: 1994-2002.
58. Hutton MJ, Westwell-Roper C, Soukhatcheva G et al. Islet allograft rejection is independent of toll-like receptor signaling in mice. Transplantation 2009; 88: 1075-1080.
59. Oberbarnscheidt MH, Obhrai JS, Williams AL et al. Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8 memory T cells. Am J Transplant 2010; 10: 162-167.
60. Li H, Matte-Martone C, Tan HS et al. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol 2011; 186: 230-241.
61. Bingaman AW, Ha J, Waitze SY et al. Vigorous allograft rejection in the absence of danger. J Immunol 2000; 164: 3065-3071.
62. Anderson C, Carroll JM, Gallucci S et al. Testing time-, ignorance-, and danger-based models of tolerance. J Immunol 2001; 166: 3663-3671.
63. Anderson CC, Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med 2001; 7: 80-87.
64. Chan WF, Perez-Diez A, Razavy H et al. The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct 2007; 2: 10.
65. Zecher D, Li Q, Oberbarnscheidt MH et al. NK cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of CD8 T cells. J Immunol 2010; 184: 6649-6657.
66. Burnet FM. 'Self-recognition' in colonial marine forms and flowering plants in relation to the evolution of immunity. Nature 1971; 232: 230-235.
67. Rosengarten RD, Nicotra ML. Model systems of invertebrate allorecognition. Curr Biol 2011; 21: R82-R92.
68. Oberbarnscheidt MH, Lakkis FG. Innate allorecognition. Immunol Rev 2014; 258: 145-149.
69. Zecher D, van Rooijen N, Rothstein D et al. An innate response to allogeneic nonself mediated by monocytes. J Immunol 2009; 183: 7810-7816.